Related Experiment Video
Updated: Mar 21, 2026

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Patent Foramen Ovale: Stroke and Device Closure
Hussam S Suradi1, Ziyad M Hijazi2
1Interventional Cardiology, Rush Center for Congenital & Structural Heart Disease, Rush University Medical Center, 1653 W Congress Pkwy, Chicago, IL 60612, USA; Department of Cardiology, St Mary Medical Center, Community HealthCare Network, Community Healthcare System, 1500 South Lake Park Avenue, Suite 110, Hobart, IN 46342, USA.
Insights
Patent foramen ovale (PFO) is linked to cryptogenic stroke. This review examines PFO closure device efficacy for preventing recurrent strokes, despite ongoing debate.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Patent foramen ovale (PFO) is a common cardiac anomaly in adults.
- PFO is frequently associated with cryptogenic stroke, a stroke of unknown cause.
- Microemboli traversing a PFO are hypothesized to cause stroke.
Purpose of the Study:
- To review the association between PFO and cryptogenic stroke.
- To evaluate the current evidence for PFO device closure in stroke prevention.
Main Methods:
- Literature review of studies and randomized trials.
- Analysis of the association between PFO and stroke pathogenesis.
- Assessment of PFO closure device efficacy.
Main Results:
- Numerous studies and trials have investigated PFO closure for stroke prevention.
- Significant debate continues regarding the definitive efficacy of PFO closure.
- Medical therapy and PFO closure are proposed treatment options.
Conclusions:
- The role of PFO in cryptogenic stroke remains a subject of ongoing research and clinical debate.
- Evidence for PFO device closure in reducing recurrent stroke risk is still being established.
Abstract:
Patent foramen ovale (PFO) is a common finding in healthy adults and has long been implicated in cryptogenic stroke. The pathogenesis is hypothesized to be caused by microemboli gaining access into the systemic circulation via a PFO. Proposed treatment options include medical therapy and/or PFO closure. Despite numerous studies and several randomized trials, much debate persists regarding the efficacy of this approach in reducing the risk of recurrent stroke in cryptogenic stroke patients. This article reviews the association between PFO and cryptogenic stroke, as well as current evidence for PFO device closure.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management
Mitral Stenosis II: Clinical features and Diagnostic Tests

